PharmaShots | Incisive News in 3 Shots

Subscribe Now

Italfarmaco Group

Italfarmaco Group Receives EMA’s Validation of MAA for Givinostat to Treat Duchenne Muscular Dystrophy

Italfarmaco Group Receives EMA’s Validation of MAA for Givinostat to Treat Duchenne Muscular Dystrophy

September 5, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us